CHRM3 is a novel prognostic factor of poor prognosis in patients with endometrial carcinoma.
about
Prognostic significance of Traf2- and Nck- interacting kinase (TNIK) in colorectal cancer.High expression of muscarinic acetylcholine receptor 3 predicts poor prognosis in patients with pancreatic ductal adenocarcinomaThe Functional Haplotypes of CHRM3 Modulate mRNA Expression and Associate with Bladder Cancer among a Chinese Han Population in Kaohsiung City.Establishment of a nine-gene prognostic model for predicting overall survival of patients with endometrial carcinoma.
P2860
CHRM3 is a novel prognostic factor of poor prognosis in patients with endometrial carcinoma.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
CHRM3 is a novel prognostic fa ...... ts with endometrial carcinoma.
@ast
CHRM3 is a novel prognostic fa ...... ts with endometrial carcinoma.
@en
type
label
CHRM3 is a novel prognostic fa ...... ts with endometrial carcinoma.
@ast
CHRM3 is a novel prognostic fa ...... ts with endometrial carcinoma.
@en
prefLabel
CHRM3 is a novel prognostic fa ...... ts with endometrial carcinoma.
@ast
CHRM3 is a novel prognostic fa ...... ts with endometrial carcinoma.
@en
P2093
P2860
P1476
CHRM3 is a novel prognostic fa ...... ts with endometrial carcinoma.
@en
P2093
Shanyun Wen
Xiaomei Yang
Yahui Wang
Yanli Zhang
Zhigang Zhang
Zhijie Wang
P2860
P304
P407
P577
2015-05-15T00:00:00Z